MX2021011389A - Compuestos de imidazolonilquinolina y usos terapeuticos de los mismos. - Google Patents

Compuestos de imidazolonilquinolina y usos terapeuticos de los mismos.

Info

Publication number
MX2021011389A
MX2021011389A MX2021011389A MX2021011389A MX2021011389A MX 2021011389 A MX2021011389 A MX 2021011389A MX 2021011389 A MX2021011389 A MX 2021011389A MX 2021011389 A MX2021011389 A MX 2021011389A MX 2021011389 A MX2021011389 A MX 2021011389A
Authority
MX
Mexico
Prior art keywords
imidazolonylquinoline
compounds
therapeutic uses
methoxy
atropisomers
Prior art date
Application number
MX2021011389A
Other languages
English (en)
Inventor
Thomas Fuchss
Axel Becker
Holger Kubas
Ulrich Graedler
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of MX2021011389A publication Critical patent/MX2021011389A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4738Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05Isotopically modified compounds, e.g. labelled
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a atropisómeros, formas sólidas, formas de sal y derivados deuterados del inhibidor de ATM 8-(1,3-dimetil-1H-pirazol-4-il)-1-(3-fluoro-5-metoxi-piridin-4-il )-7-metoxi-3-metil-1,3-dihidroimidazo[4,5-c]quinolin-2-ona así como sus composiciones. Los atropisómeros estables no se interconvierten y están representados por las siguientes fórmulas: (ver Fórmulas). Compuesto 1 Compuesto 2.
MX2021011389A 2019-03-27 2020-03-25 Compuestos de imidazolonilquinolina y usos terapeuticos de los mismos. MX2021011389A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19165664 2019-03-27
PCT/EP2020/058425 WO2020193660A1 (en) 2019-03-27 2020-03-25 Imidazolonylquinoline compounds and therapeutic uses thereof

Publications (1)

Publication Number Publication Date
MX2021011389A true MX2021011389A (es) 2021-10-13

Family

ID=65995619

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021011389A MX2021011389A (es) 2019-03-27 2020-03-25 Compuestos de imidazolonilquinolina y usos terapeuticos de los mismos.

Country Status (13)

Country Link
US (1) US20220144828A1 (es)
EP (1) EP3947375B1 (es)
JP (1) JP2022526926A (es)
KR (1) KR20210143263A (es)
CN (1) CN113614083A (es)
AU (1) AU2020247451A1 (es)
BR (1) BR112021018950A2 (es)
CA (1) CA3134874A1 (es)
IL (1) IL286079A (es)
MX (1) MX2021011389A (es)
SG (1) SG11202110480YA (es)
WO (1) WO2020193660A1 (es)
ZA (1) ZA202108263B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022058351A1 (en) * 2020-09-18 2022-03-24 Merck Patent Gmbh Pharmaceutical preparation
CA3233166A1 (en) * 2021-10-06 2023-04-13 Michal ACHMATOWICZ Methods for separation of enantiomers
KR20230059262A (ko) 2021-10-26 2023-05-03 주식회사 엘지에너지솔루션 이차전지의 저전압 불량 판정 시스템 및 이를 이용한 이차전지의 불량 판정 방법
CN115716829A (zh) * 2022-11-13 2023-02-28 药康众拓(江苏)医药科技有限公司 一种喹啉并咪唑酮联氘代吡唑类化合物及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016155844A1 (en) 2015-03-31 2016-10-06 Nec Europe Ltd. Method and system for observing a predetermined monitoring area
RS62082B1 (sr) 2015-04-02 2021-08-31 Merck Patent Gmbh Imidazolonilhinolini i njihova primena kao inhibitora atm kinaze

Also Published As

Publication number Publication date
ZA202108263B (en) 2024-04-24
CA3134874A1 (en) 2020-10-01
US20220144828A1 (en) 2022-05-12
EP3947375A1 (en) 2022-02-09
EP3947375B1 (en) 2024-04-03
CN113614083A (zh) 2021-11-05
SG11202110480YA (en) 2021-10-28
WO2020193660A1 (en) 2020-10-01
IL286079A (en) 2021-10-31
JP2022526926A (ja) 2022-05-27
AU2020247451A1 (en) 2021-11-18
BR112021018950A2 (pt) 2022-01-18
KR20210143263A (ko) 2021-11-26

Similar Documents

Publication Publication Date Title
MX2021011389A (es) Compuestos de imidazolonilquinolina y usos terapeuticos de los mismos.
MX2022005399A (es) Compuestos.
PH12020552004A1 (en) Heterocyclic compounds as kinase inhibitors, compositions comprising the heterocyclic compound, and methods of use thereof
GEP20207105B (en) 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2yl carbamate derivatives as magl inhibitors
GEP20217242B (en) Pyrazolo[1,5-a]pyrazin-4-yl derivatives as jak-inhibitors
MX2022010520A (es) Macrociclos peptidicos contra acinetobacter baumannii.
GEP20156285B (en) Compounds and compositions as trk inhibitors
MY196749A (en) Eif4a-inhibiting compounds and methods related thereto
MX2019001096A (es) Antagonistas del receptor 7/8 tipo toll (tlr7/8) y uso de los mismos.
PT2421879E (pt) Novos 7-deazapurina nucleósidos para utilizações terapêuticas
EP4275756A3 (en) Bipyrazole derivatives as jak inhibitors
EP4248968A3 (en) Tlr7/8 antagonists and uses thereof
MX2021000093A (es) Antagonistas del receptor de tipo toll 7/8 (tlr7/8) y usos de los mismos.
PH12019550140A1 (en) Piperidine-substituted mnk inhibitors and methods related thereto
MX2020009234A (es) Compuestos de heteroarilo como inhibidores de cinasas asociadas con receptores de interleucina-1 (irak) tipo ii y usos de los mismos.
EA201992090A1 (ru) ДЕЙТЕРИРОВАННЫЕ СОЕДИНЕНИЯ ИМИДАЗО[4,5-c]ХИНОЛИН-2-ОНА И ИХ ПРИМЕНЕНИЕ В ЛЕЧЕНИИ РАКА
MX2017011978A (es) Analogos deuterados de etifoxina, sus derivados y usos de estos.
ZA202201364B (en) Deuterated compounds for use in the treatment of cancer
CR20210513A (es) Compuestos de haxahidro 1-h-pirazino[1,2-a]pirazina para el tratamiento de una enfermedad autoinmunitaria
PH12020551494A1 (en) Substituted imidazolidin-2-one derivatives as prmt5 inhibitors
EA201991355A1 (ru) Производные имидазо[1,5-а]пиразина в качестве ингибиторов pi3kдельта
MX2016003422A (es) Imidazo[1,2-a]piridina-7-aminas como herramientas de imagen.
PH12020551343A1 (en) 7-substituted sulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of liver cancer
TN2021000025A1 (en) Novel heterocyclic amine derivative and pharmaceutical composition comprising same
PH12020552186A1 (en) Cyanotriazole compounds and uses thereof